Stromal Antigen Targeting by a Humanised Monoclonal Antibody: An Early Phase II Trial of Sibrotuzumab in Patients with Metastatic Colorectal Cancer

Publisher： Karger

E-ISSN： 2296-5262|26|1|44-48

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.26, Iss.1, 2003-03, pp. : 44-48

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Retraction: “Radioimmunotherapy of small‐volume disease of metastatic colorectal cancer: Results of a phase II trial with the iodine‐131–labeled humanized anti–carcinoembryonic antigen antibody hMN‐14,”

By  

CANCER, Vol. 121, Iss. 13, 2015-07 ,pp. : 2290-2290

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase II Trial of Oxaliplatin and Tegafur/Uracil and Oral Folinic Acid for Advanced or Metastatic Colorectal Cancer in Elderly Patients

By  

Oncology, Vol. 69, Iss. 2, 2005-09 ,pp. : 122-129

Karger

Access to resources Recommend Favorite

A Phase II Trial of Combined Chemotherapy with Oral S-1 and 24-Hour Infusions of Irinotecan plus Bevacizumab in Patients with Metastatic Colorectal Cancer

By  

Oncology, Vol. 88, Iss. 6, 2015-0 ,pp. : 353-359

Karger

Access to resources Recommend Favorite

A Phase II Trial of Gallium Nitrate in Patients with Androgen-Metastatic Prostate Cancer

By  

Urologia Internationalis, Vol. 63, Iss. 2, 1999-12 ,pp. : 120-125

Karger

Access to resources Recommend Favorite

Phase II Clinical Trial of Titanocene Dichloride in Patients with Metastatic Breast Cancer

By  

Oncology Research and Treatment, Vol. 23, Iss. 1, 2000-03 ,pp. : 60-62

Karger

Access to resources Recommend Favorite